Woodcock: FDA may have misstepped before Alzheimers drug approval – STAT

WASHINGTON Acting Food and Drug Administration Commissioner Janet Woodcock acknowledged on Wednesday her agency may have misstepped in its handling of its polarizing approval of a new Alzheimers drug… [+4870 chars]